KeraNetics

Focus: KeraNetics is a biotechnology company specializing in human-derived keratin-based therapeutics for oncology and dermatology indications. The company operates from Winston-Salem, NC with a focused pipeline in wound care and cancer supportive care.

Oncology Dermatology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About KeraNetics

AI assessmentNot Hiring

No open roles listed right now. Follow KeraNetics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

4 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

KeraStat Cream

Head and Neck Cancer

N/A

Clinical Trials (1)

NCT04173247Study of KeraStat Cream for Radiation Dermatitis During Head and Neck Radiotherapy

N/A

Help build intelligence for KeraNetics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Niche player with proprietary keratin platform addressing unmet needs in radiation dermatitis and burn care
Early-stage biotech offering ground-floor opportunity to shape company direction and culture
Dual focus on oncology and dermatology provides career exposure across two distinct therapeutic domains

Watch Out For

No current open positions (0 active job openings) signals minimal near-term hiring or potential contraction
Early-stage funding and pipeline status unknown; company may lack capital to scale or advance programs rapidly
Limited public disclosure on financials, employee count, and clinical trial phase data suggests opacity or early stealth mode

Generated by Claude from KeraNetics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

KeraStat® Cream

Hypersensitivity

N/A

Clinical Trials (1)

NCT04058054Skin Prick Test of KeraStat® Cream

N/A

KeraStat

Radiation Dermatitis

N/A

Clinical Trials (1)

NCT03559218KeraStat(R) Cream for Radiation Dermatitis

N/A